• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Cbz-L-pyroglutamic acid (CAS No. 32159-21-0): An Overview of Its Structure, Applications, and Recent Research

Cbz-L-pyroglutamic acid (CAS No. 32159-21-0) is a versatile compound that has garnered significant attention in the fields of organic chemistry, biochemistry, and pharmaceutical research. This compound, also known as N-Carbobenzyloxy-L-pyrrolidone-5-carboxylic acid, is a protected form of L-pyroglutamic acid, which is a cyclic derivative of the amino acid glutamic acid. The Cbz (carbobenzyloxy) protecting group is commonly used in peptide synthesis to prevent unwanted side reactions and to facilitate the controlled deprotection of the amino group.

The chemical structure of Cbz-L-pyroglutamic acid is characterized by a benzyl ring attached to the nitrogen atom of the pyrrolidone ring through a carbonyl group. This structure provides stability and reactivity that are crucial for its use in various synthetic processes. The compound is typically synthesized by the reaction of L-pyroglutamic acid with benzyl chloroformate in the presence of a base such as sodium hydroxide or triethylamine.

One of the primary applications of Cbz-L-pyroglutamic acid is in the synthesis of peptides and proteins. The Cbz protecting group allows for the sequential addition of amino acids in a controlled manner, ensuring that only the desired peptide sequence is formed. This is particularly important in the production of therapeutic peptides, where precise control over the sequence and purity of the final product is essential.

Recent research has highlighted several novel applications of Cbz-L-pyroglutamic acid. For instance, a study published in the *Journal of Medicinal Chemistry* explored its use as a building block in the synthesis of small molecules with potential anti-cancer properties. The researchers found that derivatives of Cbz-L-pyroglutamic acid exhibited significant cytotoxic activity against various cancer cell lines, suggesting its potential as a lead compound for further drug development.

In another study, published in *Bioorganic & Medicinal Chemistry Letters*, scientists investigated the role of Cbz-L-pyroglutamic acid in modulating protein-protein interactions. The compound was used to synthesize peptides that could selectively bind to specific protein domains, thereby disrupting their function. This approach has potential applications in developing inhibitors for protein-protein interactions that are implicated in diseases such as Alzheimer's and Parkinson's.

The stability and reactivity of Cbz-L-pyroglutamic acid make it an attractive candidate for use in combinatorial chemistry. Combinatorial libraries generated using this compound have been used to screen for molecules with diverse biological activities, including enzyme inhibitors and receptor agonists/antagonists. This has led to the discovery of several promising lead compounds for drug development.

Furthermore, Cbz-L-pyroglutamic acid has been utilized in the development of prodrugs. Prodrugs are inactive precursors that are converted into active drugs within the body through metabolic processes. By attaching a Cbz protecting group to a biologically active molecule, researchers can improve its pharmacokinetic properties, such as solubility and bioavailability. A recent study published in *Molecular Pharmaceutics* demonstrated that prodrugs derived from Cbz-L-pyroglutamic acid showed enhanced stability and prolonged release profiles compared to their unprotected counterparts.

The versatility of Cbz-L-pyroglutamic acid extends beyond its use in synthetic chemistry. It has also been explored for its potential therapeutic applications. For example, a study published in *Pharmacological Research* investigated its effects on neurodegenerative diseases. The researchers found that derivatives of Cbz-L-pyroglutamic acid could protect neurons from oxidative stress and reduce inflammation, suggesting its potential as a neuroprotective agent.

In conclusion, Cbz-L-pyroglutamic acid (CAS No. 32159-21-0) is a valuable compound with a wide range of applications in organic synthesis, peptide chemistry, and pharmaceutical research. Its unique chemical structure and properties make it an essential tool for researchers working on drug discovery and development. Ongoing research continues to uncover new uses and potential therapeutic applications for this versatile compound.

• 28697-11-2((S)-1-((Benzyloxy)carbonyl)piperidine-2-carboxylic Acid)
• 71170-88-2(N-Carbobenzylxoy-2-piperdinecarboxylic Acid)
• 1148-11-4(Carbobenzoxyproline)
• 225386-32-3(Z-N-Me-l-2-aminohexanoic acid)
• 1160-54-9(Z-Gly-pro-oh)
• 28697-07-6(1,\u200b2-\u200bPiperidinedicarboxyl\u200bic Acid 1-\u200b(Phenylmethyl) Ester)
• 1152-61-0(Z-Asp-OH)
• 1152-62-1(Z-Met-OH)
• 6404-31-5((2R)-1-benzyloxycarbonylpyrrolidine-2-carboxylic acid)
• 5618-96-2(Z-DL-Pro-OH)